C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) C07K 7/08 (2006.01) C12N 5/16 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2623530
The invention relates to antibodies directed against APRIL (A Proliferation Inducing TNF Ligand, also known as TALL-2) , in particular the monoclonal antibody Aprily-2, hybridoma cells producing monoclonal antibody Aprily-2, and the use of a combination of an antibody against membrane-anchored APRIL and Aprily-2 in the diagnosis of B cell lymphoma resistance to treatment and the prognosis of clinical development of Diffuse Large B-CeII (DLBCL) lymphoma from high risk patients (> 60 years and International Prognostic Index > 2) . An amino acid sequence GTGGPSQNGEGYP called Stalk, useful in the preparation of antibodies, is described.
L'invention a pour objet des anticorps dirigés contre APRIL (A Proliferation Inducing TNF Ligand, aussi connu sous le nom de TALL-2), en particulier l'anticorps monoclonal Aprily-2, des cellules hybridome qui produisent l'anticorps monoclonal Aprily-2, et l'utilisation d'une combinaison d'un anticorps anti-APRIL et anti-Aprily-2 ancré dans une membrane dans le diagnostic de la résistance au traitement du lymphome à cellules B et le pronostic de l~évolution clinique du lymphome diffus à grandes cellules B (DLBCL) de patients à hauts risques (> 60 ans et index pronostique international > 2) . Une séquence d'acides aminés GTGGPSQNGEGYP appelé Stalk, utile dans la préparation d'anticorps, est décrite.
Donze Olivier
French Lars
Huard Bertrand
Murone Maximilien
Apotech Corporation
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Enzo Life Sciences Inc.
University Of Geneva
LandOfFree
Antibodies against april as biomarkers for early prognosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against april as biomarkers for early prognosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against april as biomarkers for early prognosis... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1461681